# ENDIOS BIO, INC.: Development of antisense oligonucleotides against PEG10 in the fight against ALS-FTD

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | ENDIOS BIO, INC. |
| Location | BATON ROUGE, LA |
| Project | Development of antisense oligonucleotides against PEG10 in the fight against ALS-FTD |
| Project number | 1R43NS147623-01A1 |
| Mechanism | R43 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $444,820 |
| Awarded | 2026-09-18 |
| Project period | 2026-09-18 to 2028-08-31 |
| UEI | EUA8B6E2TJF5 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11408359). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.